Top

Published in:

01-10-2018 | IM - COMMENTARY

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey

Authors: Giuseppe Mulè’, Caterina Carollo, Marco Guarneri, Santina Cottone

Published in: Internal and Emergency Medicine | Issue 7/2018

Excerpt

Atrial fibrillation is the most common sustained cardiac dysrhythmia. It represents a major public health problem due to increased mortality risk, reduced quality of life, and increased health costs [1, 2]. …

Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609–1678CrossRefPubMed

January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 64:2245–2280. https://doi.org/10.1016/j.jacc.2014.03.021 CrossRef

Chugh SS, Roth GA, Gillum RF, Mensah GA (2014) Global burden of atrial fibrillation in developed and developing nations. Glob Heart 9:113–119. https://doi.org/10.1016/j.gheart.2014.01.004 CrossRefPubMed

Krijthe BP, Kunst A, Benjamin EJ et al (2013) Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34:2746–2751. https://doi.org/10.1093/eurheartj/eht280 CrossRefPubMedPubMedCentral

Healey JS, Alings M, Ha A et al (2017) Subclinical atrial fibrillation in older patients. Circulation 136:1276–1283. https://doi.org/10.1161/CIRCULATIONAHA.117.028845 CrossRefPubMed

Ferro D, Loffredo L, Polimeni L, Violi F (2007) Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy. Intern Emerg Med 2:24–28. https://doi.org/10.1007/s11739-007-0005-2 CrossRefPubMedPubMedCentral

Ogilvie IM, Newton N, Welner SA et al (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638.e4–645.e4. https://doi.org/10.1016/J.AMJMED.2009.11.025 CrossRef

Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891. https://doi.org/10.1056/NEJMoa1009638 CrossRefPubMed

Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962. https://doi.org/10.1016/S0140-6736(13)62343-0 CrossRefPubMed

10.

Larsen TB, Skjøth F, Nielsen PB et al (2016) Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ 353:i3189. https://doi.org/10.1136/BMJ.I3189 CrossRefPubMedPubMedCentral

11.

Prisco D, Ageno W, Becattini C et al (2017) Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 12:387–406. https://doi.org/10.1007/s11739-017-1628-6 CrossRefPubMed

12.

Borghi C, Paolillo S, Cicero AFG et al (2017) New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation. J Hypertens 35:689–695. https://doi.org/10.1097/HJH.0000000000001228 CrossRefPubMed

13.

Hsu JC, Maddox TM, Kennedy KF et al (2016) Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk. JAMA Cardiol 1:55. https://doi.org/10.1001/jamacardio.2015.0374 CrossRefPubMed

14.

Kjerpeseth LJ, Ellekjær H, Selmer R et al (2017) Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Eur J Clin Pharmacol 73:1417–1425. https://doi.org/10.1007/s00228-017-2296-1 CrossRefPubMed

15.

Gülker J-E, Kröger K, Kowall B et al (2018) Increasing use of anticoagulants in Germany and its impact on hospitalization for intracranial bleeding. Circ Cardiovasc Qual Outcomes 11:e004470. https://doi.org/10.1161/CIRCOUTCOMES.117.004470 CrossRefPubMed

16.

Volterrani M, Iellamo F, Alberto C et al (2018) NOAC in “real world” patients with atrial fibrillation in Italy: results from the ISPAF-2 (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study. 2 Intern Emerg Med. https://doi.org/10.1007/s11739-018-1896-9 (in press) CrossRefPubMed

17.

Huisman MV, Rothman KJ, Paquette M et al (2017) The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2. J Am Coll Cardiol 69:777–785. https://doi.org/10.1016/j.jacc.2016.11.061 CrossRefPubMed

Title: The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey
Authors: Giuseppe Mulè’
Caterina Carollo
Marco Guarneri
Santina Cottone
Publication date: 01-10-2018
Publisher: Springer International Publishing
Published in: Internal and Emergency Medicine / Issue 7/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-018-1929-4

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2018

Reliability of the CARE rule and the HEART score to rule out an acute coronary syndrome in non-traumatic chest pain patients

A severe case of epigastric pain, diarrhea and coffee ground vomitus

Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists

Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Penile self-amputation

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page